[ad_1]
New Delhi: Drug firm Natco Pharma on Saturday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur facility in Telangana. The United States Food and Drug Administration (USFDA) had conducted pre-approval inspection at the company’s drug formulations facility in Kothur village during the period from March 2 to 6, 2020, Natco Pharma said in a filing to the BSE. The EIR signifies successful closure of inspection by the regulator, it added.
[ad_2]
Source link
in Business
Natco Pharma gets EIR from USFDA for Telangana facility
